Error: Could not add to watchlist. X

Clovis Oncology Inc

+ Watchlist
CLVS:US
NASDAQ GS
84.95
USD
1.59
1.91%
As of 09:54:44 ET on 09/03/2015.
Open
84.10
Day Range
83.60 - 85.01
Volume
47,988
Previous Close
83.36
52Wk Range
39.45 - 102.28
1 Yr Return
88.76%
Open
84.10
Day Range
83.60 - 85.01
Volume
47,988
Previous Close
83.36
52Wk Range
39.45 - 102.28
1 Yr Return
88.76%
YTD Return
51.68%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-6.75
Market Cap (b USD)
3.185
Shares Outstanding (m)
38.207
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.
ADDRESS
2525 28th Street
Suite 100
Boulder, CO 80301
United States
PHONE
1-303-625-5000
  • Patrick J Mahaffy
    President/CEO/Co-Founder
  • Erle T Mast
    Exec VP/CFO/Secy/Co-Founder
  • Steven L Hoerter
    Exec VP/Chief Commercial Ofcr
  • Lindsey Rolfe
    Exec VP:Clinical & Preclinical Dev & Pharmacovigilance
  • Anna Sussman
    Senior VP:Investor Relations
Show More